BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24331628)

  • 1. [Clinical value of iodine [131I] metuximab infusion combined with TACE for treatment of patients with post-intervention relapse of mid or advanced stage hepatocellular carcinoma].
    Li Z; Zhou JX; Ren JZ; Zhang WJ; Han XW
    Zhonghua Gan Zang Bing Za Zhi; 2013 Oct; 21(10):728-33. PubMed ID: 24331628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 131I-Labeled-Metuximab Plus Transarterial Chemoembolization in Combination Therapy for Unresectable Hepatocellular Carcinoma: Results from a Multicenter Phase IV Clinical Study.
    Ma J; Wang JH
    Asian Pac J Cancer Prev; 2015; 16(17):7441-7. PubMed ID: 26625741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization.
    Wu F; Wang ZB; Chen WZ; Zou JZ; Bai J; Zhu H; Li KQ; Jin CB; Xie FL; Su HB
    Radiology; 2005 May; 235(2):659-67. PubMed ID: 15858105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma.
    He Q; Lu WS; Liu Y; Guan YS; Kuang AR
    World J Gastroenterol; 2013 Dec; 19(47):9104-10. PubMed ID: 24379637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of the efficacy and safety of iodine [
    Fan W; Wu Y; Lu M; Yao W; Cui W; Zhao Y; Wang Y; Li J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):451-459. PubMed ID: 30348520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Curative effect of a comprehensive interventional treatment modality on hepatocellular carcinoma complicated with main branch portal vein tumor thrombosis].
    Xu GB; Xiong B; Long QY
    Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):367-71. PubMed ID: 24025139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of postoperative antiviral combined transcatheter arterial chemoembolization therapy in prevention of hepatitis B-related hepatocellular carcinoma recurrence.
    Yan Q; Ni J; Zhang GL; Yao X; Yuan WB; Zhou L; Zheng SS
    Chin Med J (Engl); 2013 Mar; 126(5):855-9. PubMed ID: 23489790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
    Fan WJ; Zhang L; Ouyang YS
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2474-7. PubMed ID: 19080627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.
    Malagari K; Pomoni M; Kelekis A; Pomoni A; Dourakis S; Spyridopoulos T; Moschouris H; Emmanouil E; Rizos S; Kelekis D
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):541-51. PubMed ID: 19937027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
    Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma.
    Imai N; Ikeda K; Seko Y; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Oncology; 2011; 80(3-4):188-94. PubMed ID: 21709428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Artery Injection of
    Chen H; Nan G; Wei D; Zhai RY; Huang M; Yang WW; Xing BC; Zhu X; Xu HF; Wang XD; Zhang XY; Zhu BR; Liu P; Cao G; Gao S; Hao CY; Yang RJ; Guo JH; Zhang X; Gao K; Wang K; Wang JF; Li ZY; Zhu LZ; Ding R; Li J; Zhao L; Shao YJ; Liu HC; Xia JL; Wang L; Kong LM; Chen ZN; Bian H
    J Nucl Med; 2022 Apr; 63(4):556-559. PubMed ID: 34475235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter Arterial Chemoembolization Plus
    Zhu ZX; Liao MH; Wang XX; Huang JW
    Korean J Radiol; 2016; 17(6):882-892. PubMed ID: 27833404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
    Gomes AS; Rosove MH; Rosen PJ; Amado RG; Sayre JW; Monteleone PA; Busuttil RW
    AJR Am J Roentgenol; 2009 Dec; 193(6):1665-71. PubMed ID: 19933662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma.
    Li C; Zhang W; Zhang R; Zhang L; Wu P; Zhang F
    Eur J Cancer; 2010 Sep; 46(13):2513-21. PubMed ID: 20663659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
    Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of [131I] metuximab in treatment of hepatocellular carcinoma after percutaneous radiofrequency ablation.
    Bian H; Zheng JS; Nan G; Li R; Chen C; Hu CX; Zhang Y; Sun B; Wang XL; Cui SC; Wu J; Xu J; Wei D; Zhang X; Liu H; Yang W; Ding Y; Li J; Chen ZN
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25210200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.